Recombination frequencies of human leukocyte antigen loci in hematological malignancies among Turkish population.

International Journal of Laboratory Hematology
Cigdem KekikFatma Savran Oguz

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option with growing performance for leukaemia, aplastic anaemia and genetic disorders. The frequency of MHC (Major Histocompatibility Complex) gene locus recombination is increased at loci close to the telomeres and in the female gender. The aim of the present study is to document the recombination events by pedigree diagrams with the primary goal to determine the frequency of recombination in a different ethnic population from mostly reported studies. Altogether 9545 allogeneic HSCT recipients and their family-based potential donors (n:36231) were included in this retrospective study. Recombinations were determined in 118 (F/M:50/68) out of 9545 families enrolled on the study. These were present in 40 of the patients and 78 of healthy donors. The frequency of recombinations was 0.42% and 0.22%, in patients and donors, respectively. Of the 118 recombinations, 60 were detected in A locus (13 inpatients), 14 in B locus (3 inpatients) and 42 in DR locus (22 inpatients). In our study, due to recombinations in HLA (Human Leukocyte Antigen)-A,-B,-DR loci, we found that some patient-donor pairs became 6/5 matched instead of 6/6 (n:45), eliminating the allogeneic ...Continue Reading

References

Oct 23, 1987·Cell·H Donis-KellerE S Lander
Jan 1, 1993·Tissue Antigens·O Olerup, H Zetterguist
Jan 23, 1998·Human Immunology·K A SullivanM Bryer-Ash
Aug 27, 1998·American Journal of Human Genetics·K W BromanJ L Weber
Oct 5, 2001·Nature Genetics·M J DalyE S Lander
Sep 13, 2002·Clinical Transplantation·M MuroM R Alvarez-López
Sep 26, 2002·American Journal of Human Genetics·Michael CullenMary Carrington
Sep 16, 2004·Pediatric Transplantation·Asa Gustafsson JernbergJacek Winiarski
Aug 2, 2007·Methods in Molecular Medicine·Berthold Hoppe, Abdulgabar Salama
Jan 20, 2018·European Annals of Allergy and Clinical Immunology·S BüyüköztürkF Oğuz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.